The Evolving Role of TKIs in First-line Treatment of Advanced HCC
CCO Oncology Podcast - A podcast by Clinical Care Options
Categories:
In this podcast episode, experts Josep M. Llovet, MD, PhD, and Univ. Prof. Markus Peck-Radosavljevic, MD, MBA, discuss the evolving role of tyrosine kinase inhibitors in the first-line treatment of patients with advanced hepatocellular carcinoma.
